Mangoceuticals (MGRX) Income from Continuing Operations (2023 - 2026)
Mangoceuticals (MGRX) posted Income from Continuing Operations of 3403141.0 for Q1 2026, down 22.89% sequentially from 2769370.0 in Q4 2025, and up 29.68% YoY from 2624265.65 in Q1 2025.
Mangoceuticals (MGRX) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Mangoceuticals has reported Income from Continuing Operations for 4 years, with the latest figure at 3403141.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 29.68% year-over-year to 3403141.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19207107.0 (down 71.81% YoY) and the FY2025 annual result came in at 16308330.0, down 137.08% from the prior year.
- Income from Continuing Operations declined to 3403141.0 in Q1 2026 per MGRX's latest filing, from 2769370.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 1799460.0 in Q3 2023 and troughed at 7618776.0 in Q3 2025.
- A 4-year average of 3228172.23 and a median of 2560885.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2025 and 2026: Income from Continuing Operations sank 281.0% in 2025, then rose 29.68% in 2026.
- Over 4 years, Income from Continuing Operations stood at 2568047.0 in 2023, then increased by 24.12% to 1948596.0 in 2024, then tumbled by 42.12% to 2769370.0 in 2025, then declined by 22.89% to 3403141.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 3403141.0, 2769370.0, and 7618776.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 86.60 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 69.42 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | -17.93 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 43.69 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | -185.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 40.87 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 24.32 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | -15.74 Mn |
| 10 | Mangoceuticals | 9.55 Mn | 9.30 Mn | 44,215.00 | -1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.31 Mn |
| Mar 31, 2026 | -3.40 Mn |
| Dec 31, 2025 | -2.77 Mn |
| Sep 30, 2025 | -7.62 Mn |
| Jun 30, 2025 | -5.42 Mn |
| Mar 31, 2025 | -4.84 Mn |
| Dec 31, 2024 | -1.95 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Jun 30, 2024 | -2.39 Mn |
| Mar 31, 2024 | -2.37 Mn |
| Dec 31, 2023 | -2.57 Mn |
| Sep 30, 2023 | -1.80 Mn |
| Jun 30, 2023 | -2.28 Mn |
| Mar 31, 2023 | -2.56 Mn |